Bezos-Backed Flourish Raises $500M to Decode Brain Algorithms

A neuroscience moonshot gets massive backing

Jeff Bezos has committed $500 million to Flourish, an ambitious neuroscience startup that believes the future of artificial intelligence lies in understanding how biological brains actually work. The company has reached a reported valuation of $2.5 billion as it pursues what it calls the brain's "core algorithm."

According to details first reported by WIRED, Flourish is taking a fundamentally different approach to AI development by putting real neurons under the microscope rather than simply scaling up existing machine learning architectures. The company's founder, Rob Williams, secured Bezos's backing using the Amazon founder's signature evaluation method: writing a press release as if the product already exists and waiting for a thumbs up or down.

Why it matters

This investment signals a potential shift in how the tech industry thinks about AI development. While most companies are racing to build larger language models and neural networks, Flourish is betting that biological intelligence holds secrets that pure computational approaches have missed. If successful, understanding the brain's fundamental algorithms could unlock AI capabilities that current architectures cannot achieve, potentially leapfrogging the incremental improvements that have defined recent AI progress.

The biological intelligence bet

Flourish's approach represents a departure from the dominant paradigm in AI research, which has focused on creating artificial neural networks inspired by—but not directly modeled on—biological brains. By studying actual neurons and their interactions, the company hopes to identify computational principles that evolution has refined over millions of years.

The $500 million funding round and $2.5 billion valuation place Flourish among the most valuable neuroscience-focused startups, though it remains far smaller than the AI giants like OpenAI and Anthropic. The substantial backing from Bezos, who has increasingly focused his investments on long-term scientific ventures since stepping back from Amazon's day-to-day operations, lends credibility to Flourish's unconventional approach.

A different path to artificial intelligence

The startup's work sits at the intersection of neuroscience and artificial intelligence, two fields that have grown increasingly separate despite their historical connections. Early AI research drew heavily on theories of how brains process information, but modern deep learning has largely abandoned biological plausibility in favor of what works computationally.

Flourish's hypothesis is that this divergence has left important insights on the table. By identifying what the company calls the brain's "core algorithm"—the fundamental computational principles that enable biological intelligence—it aims to create AI systems that are more efficient, adaptable, and capable than current approaches allow.

The details of Flourish's specific research methods and timeline remain limited, though the company's ability to attract both significant capital and Bezos's personal attention suggests it has convinced sophisticated investors that its biological approach to AI has merit.

These details were first reported by Steven Levy at WIRED.